ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02811861
Brief Title: Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma (CLEAR)

First Submitted : June 21, 2016
First Submitted that Met QC Criteria : June 21, 2016
First Posted : June 23, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 1, 2019
Last Update Posted : February 4, 2019